PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.66
Ask: 42.76
Change: -0.38 (-0.88%)
Spread: 0.10 (0.234%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Jul 2020 07:00

RNS Number : 1660S
Assura PLC
07 July 2020
 

7 July 2020

Assura plc

 

Trading Update

For the first quarter ending 30 June 2020

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter ending 30 June 2020.

 

Jonathan Murphy, CEO, said:

"We've had an active first quarter, as we continued to deliver strategic and financial progress across all areas of the business, despite these uncertain times for the UK. Our business model remains resilient and robust, as demonstrated by normal patterns of recent rent collections and all our development sites being active in line with social distancing guidelines.

"Our social purpose - to create outstanding primary care properties that sit at the heart of our local communities - has never been more important than it is today, and we are making good progress with our recently launched sixbysix social impact strategy.

"As lockdown restrictions gradually ease, we are working closely with our GP partners to ensure we best support the NHS and respond to evolving market needs as part of the 'new normal'. Primary care will play a crucial role as the UK seeks to rebuild and recover from the COVID-19 crisis and we are engaging with Government to ensure that it remains a key area of investment going forward."

 

Operational update

· Safety and wellbeing of our colleagues, tenants and patients our top priority

· Ongoing discussions with our tenants and the NHS on how our buildings can best support the evolving needs of GPs and patients as we gradually move out of the lockdown

· All construction sites active with appropriate social distancing measures in place

· June quarter rents being received in line with normal patterns

 

Active first quarter

· Strong portfolio of 565 properties with current annualised rent roll of £110.2 million

· Developments at Stafford and Netherfield completed (combined cost £11.9 million) - the latter is on track for a BREEAM rating of "Excellent", incorporating a number of sustainable elements including electric vehicle charging points, photovoltaic panels and an air source heat pump

· Five schemes progressed to on-site, including Stourport in Worcestershire which is part funded by NHS England's Estates and Technology Transformation Fund ("ETTF")

· Seven acquisitions completed for combined £35 million

· Portfolio of 20 assets disposed for £17 million, as disclosed in our year end results in May

· Two lease regears completed (£0.3 million of existing rent)

· One capital asset enhancement project completed and three currently on site (combined spend £0.6 million)

 

Strong pipeline for growth

· Currently on-site with 18 developments with a total cost of £95 million

· Immediate development pipeline totalling £60 million: schemes which we expect to be on site within 12 months

· Immediate acquisitions pipeline stands at £51 million, which we would normally expect to complete in three-six months

· 45 lease re-gears covering £5.6 million of existing rent roll in the current pipeline

· Pipeline of 21 capital asset enhancement projects (projected spend £15 million) over the next two years

 

Robust balance sheet

· At 30 June 2020 gross debt stood at £767 million with undrawn facilities of £300 million

· As announced with our year end results in May, the maturity of the revolving credit facility has been extended to November 2025, with the facility reducing from £300 million to £225 million with effect from May 2021

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 680

Email: Investor@assura.co.uk

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

Email: Assura@Finsbury.com

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFESDDIRIII
Date   Source Headline
18th Oct 201710:00 amRNSNotice of Results
16th Oct 20177:00 amRNSScrip Dividend Declaration
10th Oct 20177:00 amRNSAppointment of Non-Executive Director
3rd Oct 20173:01 pmRNSDirectorate Change
2nd Oct 20171:07 pmRNSNotification of Major Interests in Shares
2nd Oct 20177:00 amRNSTrading Update
25th Sep 20177:00 amRNSChief Financial Officer
21st Sep 201712:21 pmRNSScrip Calculation Price
11th Sep 20174:23 pmRNSNotification of Major Interests in Shares
8th Sep 20175:20 pmRNSPDMR Notification
7th Sep 20177:00 amRNSNotice of Dividend - Property Income Distribution
1st Sep 201711:42 amRNSTotal Voting Rights
1st Sep 201710:30 amRNSExercise of Nil Cost Options under VCP
30th Aug 20177:00 amRNSAdditional Listing
21st Aug 20171:44 pmRNSAppointment of Joint Corporate Broker
17th Aug 201712:05 pmRNSNotification of Major Interest in Shares
4th Aug 20177:00 amRNSAppointment of Chief Financial Officer
1st Aug 20177:00 amRNSTotal Voting Rights
19th Jul 20174:41 pmRNSNotification of Transactions by PDMRs
18th Jul 20172:27 pmRNSResult of AGM
18th Jul 20177:00 amRNSTrading Update
17th Jul 20177:00 amRNSScrip Dividend Declaration
3rd Jul 20179:20 amRNSCorrection of Total Voting Rights
3rd Jul 20177:00 amRNSTotal Voting Rights
22nd Jun 201711:14 amRNSScrip Calculation Price
22nd Jun 201710:14 amRNSNotification of Major Interests in Shares
22nd Jun 201710:11 amRNSNotification of Major Interests in Shares
20th Jun 20174:52 pmRNSResults of Placing
20th Jun 20177:00 amRNSProposed equity Issue of new ordinary shares
16th Jun 20174:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20173:12 pmRNSNotification of Major Interests in Shares
13th Jun 20172:56 pmRNSNotification of Major Interests in Shares
8th Jun 20177:00 amRNSNotice of Dividend
5th Jun 20174:55 pmRNSNotification of transaction by PDMR
30th May 20177:00 amRNSDirector Declaration
24th May 201711:29 amRNSCorrection of Dividend Information
23rd May 20177:00 amRNSAssura Full Year Results
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares
1st Feb 201712:54 pmRNSTotal Voting Rights
1st Feb 20177:00 amRNSTrading Update
26th Jan 20179:18 amRNSNotification of Major Interest in Shares
18th Jan 20177:00 amRNSNotification of Transaction by PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.